Scientific Seminar Series
KU Department of Pharmacology and Toxicology's Scientific Seminar Series features prominent researchers from KU, the United States and the world.
Recent Seminars
Rebecca L. Gillani, MD, Ph.D.
Neurology Instructor
Department of Neurology / Neuroimmunology and Neuro-Infectious Diseases Division, Multiple Sclerosis Clinic
Massachusetts General Hospital
Neuroinflammation Destabilizes Excitatory Synapses, Altering Excitatory Circuit Inputs to Individual Cells
| 1:00 p.m. (CST)
Zoom Meeting
Silvia Fossati, Ph. D.
Associate Professor and Associate Director
Alzheimer’s Center at Temple (ACT)
Temple University, Philadelphia, Pennsylvania
Cerebrovascular and Cardiac Dysfunction in Alzheimer's Disease and CAA; a Mitochondria-targeted Therapeutic Strategy
| 9:30 a.m. (CST)
Malott Hall, Room 2048
Jorge Palop, Ph.D.
Associate Investigator, Gladstone Institutes, and Associate Professor
Department of Neurology
UC San Francisco, San Francisco, California
Network Abnormalities and Interneuron Dysfunction in Alzheimer’s Disease
| 10:00 a.m. (CST)
School of Pharmacy, Room 1020
Jeremy Herskowitz, Ph. D.
Professor of Neuroscience
Center for Neurodegeneration and Experimental Therapeutics
Department of Neurology
Mechanisms of Synaptic Resilience to Alzheimer's Disease
| 10:00 a.m. (CST)
School of Pharmacy, Room 1020
Feixiong Cheng, Ph.D.
Assistant Professor
Case Comprehensive Cancer Center
Case Western Reserve University, Cleveland, Ohio
Harnessing Genetics, Genomics, Endophenotype, and Network Medicine for Alzheimer's Disease Target and Drug Discovery
| 9:30 a.m. (CST)
School of Pharmacy, Room 1020
Yueming Li, Ph.D.
Biochemist
Memorial Sloan Kettering Cancer Center New York, NY
Modulation of γ-secretase in Alzheimer and Cancer
| 1:00 p.m. (CST)
Zoom meeting
Jeffrey Zigman, MD, Ph.D.
Professor
Internal Medicine | Psychiatry
UT Southwestern Medical Center Dallas, TX
The Ghrelin System and Body Weight
| 10:30 a.m. (CST)
Dole Human Development Center, Room 2096
Past Seminars
| Name/Organization | Seminar Title/Date |
|---|---|
| Anna Dunaevsky, Ph.D. University of Nebraska Medical Center, Omaha NE | Neural dysfunction in Fragile X syndrome October 29, 2021 |
| Ram Madabhushi, Ph.D. UT Southwestern Medical Center, Dallas TX | Untangling the roles of DNA topology and activity-induced DNA breaks in neuronal physiology October 15, 2021 |
| Charles Abrams, M.D., Ph.D. University of Illinois at Chicago | May 14, 2020 |
| Marie-Eve Tremblay, Ph.D. CRCHU de Quebec-Laval University | Dark microglia: remodeling neuronal circuits in health and disease March 16, 2020 |
| Devanandi Manoli, M.D., Ph.D. Center for Integrative Neuroscience University of California, San Francisco | Understanding the Neural Basis of Social Attachment May 7, 2019 |
| Eduardo Candelario-Jalil, Ph.D. Dept. of Neuroscience, University of Florida | Neurovascular Protection by Adropin in Experimental Ischemic Stroke April 30, 2019 |
| Teruna Siahaan, Ph.D. Pharmaceutical Chemistry, University of Kansas | Challenges and Progress of Delivering Molecules to the Brain November 1, 2018 |
| Mark R. Cookson, Ph.D. NIH | Pathways to Parkinsonism March 15, 2018 |
| Partha Kasturi, Ph.D. University of Kansas Medical Center | Mitochondrial transporter ABcb6: An Unexpected Journey Through Haem Synthesis, Mitochondrial Dynamics and Beyond December 7, 2017 |
| Xianglin Shi, Ph.D. University of Kentucky College of Medicine | Mechanism of Cr(VI) Carcinogenesis and Prevention November 9, 2017 |
| Christopher Pittenger, M.D., Ph.D. Yale University School of Medicine | Of Mice, Men, and Tics: Translational Studies of Tourette syndrome January 27, 2017 |
| Rong Chen, Ph.D. Dept. of Physiology & Pharmacology, Wake Forest School of Medicine | RGS2: A New Modulator of Midbrain Dopamine D2 Receptor Signaling and Addiction Behavior April 29, 2016 |
| Ke Jian "Jim" Liu, Ph.D. Brain Imaging Center at the University of New Mexico | Interruption of Zinc Finger Proteins and Arsenic Carcinogenesis November 11, 2015 |
| Caroline Blanchard, Ph.D. Biosciences Center, University of Hawaii | Functional Approaches to Translation of Biobehavioral Systems April 24, 2015 |
| Nina Isoherranen, Ph.D. Dept. of Pharmaceutics, University of Washington | Vitamin A and Retinoic Acid Homeostasis in Health and Disease: Role of ALDH1A and CYP26 Enzymes Thursday, April 2, 2015 |
| Michael Garcia, Ph.D. Biological Sciences, University of Missouri-Columbia | Myelination of Peripheral Axons: It Takes a Village to Raise a Nerve February 25, 2015 |
| Liang-Jun Yat, Ph.D. Dept. of Pharmaceutical Sciences, College of Pharmacy, University of North, Texas Health Science Center | Blue Native Gel Analysis of Mitochondrial Proteins: Two Enzymes for Two Deadly Diseases March 12, 2014 |
| Maureen Kane, Ph.D. Pharmaceutical Sciences, Mass Spectronomy Center, University of Maryland School of Pharmacy | Use of Targeted Metabolomics to Probe Retinoid Metabolism February 26, 2014 |
| Irina G. Gazaryan, Ph.D. Neurology & Neuroscience, Weill Cornell Medical College | Triggering of Antioxidant Program without Electrophilic Stress October 16, 2013 |
| Paul L. Prather, Ph.D. Dept. of Pharmacology & Toxicology, College of Medicine, University of Arkansas for Medical Sciences | Synthetic Cannabinoids in K2/Spice: Not Just "Safe" Alternative Forms of Marijuana September 18, 2013 |
| Cibele Pinto, Ph.D. University of Kansas Medical Center, Kidney Institute | cAMP Signaling in Polycystic Kidney Disease: The Role of Adenylyl Cyclases and Phosphodiesterases on AVP-Mediated Cyst Formation May 8, 2013 |
| Wen-Xing, Ph.D. Dept. of Pharmacology, Toxicology & Therapeutics University of Kansas, Medical Center | Mitophagy and Mitochondrial Spheroids in Drug- Induced Liver Injury April 24, 2013 |
| Tony Passaniti, Ph.D. Dept. of Pathology, Dept. of Biochemistry & Molecular Biology, Greenbaum Cancer Center | Angiogenesis and RUNX2-Specific Drug Discovery: Implications of Diabetes & Cancer April 17, 2013 |
| Cara Wellman, Ph.D. Dept. of Psychological and Brain Sciences, Indiana University | Sweating the Small Stuff: Stress Effects on Corticolimbic Structure and Function April 3, 2013 |
| Dongsheng Cai, Ph.D. Department of Molecular Pharmacology, Albert Einstein College of Medicine | Neuroinflammation and Obesity-Related Diseases January 23, 2013 |
| Stephen Keith Chapes, Ph.D., M.P.H. Biology, Kansas State University | Understanding Host Resistance to Ehrlichia Chaffeensis: What do Bugs Have to Do with It? May 2, 2012 |
| Mark Yorek, Ph.D. Internal Medicine, University of Iowa | Vascular Disease in Diabetic Neuropathy April 11, 2012 |
| Zhenyu Yue, Ph.D. Department of Neurology & Neuroscience, Mount Sinai School of Medicine | Autophagy in Neurons and Neurodegeneration March 7, 2012 |
| Rick Allen Bevins, Ph.D. Department of Psychology, University of Nebraska-Lincoln | The Nicotine Stimulus: A New Approach to Dis-entangling its Underlying Neuropharmacological Mechanisms February 22, 2012 |
| Heng Du, Ph.D. Higuchi Biosciences Center, University of Kansas | Synaptic Mitochondrial Alterations Contribute to Synaptic Degeneration in Alzheimer's Disease December 7, 2011 |
| Nigel Calcutt Pathology, University of California San Diego | Diabetic Peripheral Neuropathy: Is the Train of Pain Caused Mainly by the Brain? April 20, 2011 |
| Michal Toborek, Ph.D. Department of Neurosurgery, Molecular Neuroscience and Vascular Biology Laboratory, University of Kentucky Medical Center | Breaking it Down: The Blood-brain Barrier in Cerbrovascular Toxicity of Environmental Pollutants March 2, 2011 |
| Stephen Fowler, Ph.D. Dept. of Pharmacology & Toxicology, University of Kansas | Using Force-plate Actometers to Characterize the Movement Abnormalities of Huntington's Disease Model Mice and Rats: Behavioral Concomitants of Striatal February 23, 2011 |